Potential neutralizing antibodies discovered for novel corona virus using machine learning
暂无分享,去创建一个
Amir Barati Farimani | Rishikesh Magar | Prakarsh Yadav | Rishikesh Magar | A. Farimani | Prakarsh Yadav
[1] John Steel,et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop , 2012, Nature.
[2] Xiaogen Zhou,et al. Protein structure and sequence re-analysis of 2019-nCoV genome does not indicate snakes as its intermediate host or the unique similarity between its spike protein insertions and HIV-1 , 2020, bioRxiv.
[3] Peter M Tessier,et al. Advances in Antibody Design. , 2015, Annual review of biomedical engineering.
[4] D. Burton,et al. A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies , 2009, Journal of Virology.
[5] Hugues Bedouelle,et al. Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. , 2012, Structure.
[6] K. Taylor,et al. Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5 , 2017, Journal of Virology.
[7] F. Plummer,et al. Structural Insights into Immune Recognition of the Severe Acute Respiratory Syndrome Coronavirus S Protein Receptor Binding Domain , 2009, Journal of Molecular Biology.
[8] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[9] Damien Fleury,et al. Antigen distortion allows influenza virus to escape neutralization , 1998, Nature Structural Biology.
[10] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[11] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[12] Alexey Bochkarev,et al. An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex. , 2005, Journal of molecular biology.
[13] Carol Carter,et al. Crystal structure of dimeric HIV-1 capsid protein , 1996, Nature Structural Biology.
[14] Joseph Gomes,et al. MoleculeNet: a benchmark for molecular machine learning† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc02664a , 2017, Chemical science.
[15] Lun Song,et al. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV , 2020, Cellular & Molecular Immunology.
[16] Michael S. Diamond,et al. Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope , 2012, PLoS pathogens.
[17] J. Skehel,et al. An antibody that prevents the hemagglutinin low pH fusogenic transition. , 2002, Virology.
[18] Yang Feng,et al. Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody* , 2006, Journal of Biological Chemistry.
[19] C. Hew,et al. Structural basis for the neutralization and genotype specificity of hepatitis E virus , 2011, Proceedings of the National Academy of Sciences.
[20] Gira Bhabha,et al. Antibody Recognition of a Highly Conserved Influenza Virus Epitope , 2009, Science.
[21] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[22] Peter D. Kwong,et al. Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope , 2004, Journal of Virology.
[23] Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking , 2020 .
[24] Yaakov Levy,et al. Simulations of proteins with inhomogeneous degrees of freedom: The effect of thermostats , 2008, J. Comput. Chem..
[25] Gerhard Hummer,et al. Native contacts determine protein folding mechanisms in atomistic simulations , 2013, Proceedings of the National Academy of Sciences.
[26] R L Stanfield,et al. Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[27] D. Baker,et al. Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold , 2011, Science.
[28] W. Schief,et al. Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus. , 2011, Journal of molecular biology.
[29] Andreas Radbruch,et al. Antibodies and B cell memory in viral immunity. , 2007, Immunity.
[30] D. van der Spoel,et al. GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .
[31] Yoshihiro Kawaoka,et al. A Shared Structural Solution for Neutralizing Ebolaviruses , 2011, Nature Structural &Molecular Biology.
[32] P. Tavan,et al. The "Hot-Solvent/Cold-Solute" Problem Revisited. , 2008, Journal of chemical theory and computation.
[33] Tongqing Zhou,et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120 , 2007, Nature.
[34] A. Walls,et al. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion , 2019, Cell.
[35] E. Stura,et al. Crystal Structure of a Hydrophobic Immunodominant Antigenic Site on Hepatitis C Virus Core Protein Complexed to Monoclonal Antibody 19D9D6 1 , 2003, The Journal of Immunology.
[36] Andreas P. Eichenberger,et al. Definition and testing of the GROMOS force-field versions 54A7 and 54B7 , 2011, European Biophysics Journal.
[37] E. Pai,et al. Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications , 2009, Journal of Virology.
[38] D. Burton,et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor , 2008, Nature.
[39] Hyejin Yoon,et al. CATNAP: a tool to compile, analyze and tally neutralizing antibody panels , 2015, Nucleic Acids Res..
[40] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[41] E. Hewitt. The MHC class I antigen presentation pathway: strategies for viral immune evasion , 2003, Immunology.
[42] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[43] G. Nybakken,et al. Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody , 2009, The EMBO journal.
[44] R. Siva,et al. Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus , 2016, Infectious Diseases of Poverty.
[45] Emma J. Chory,et al. A Deep Learning Approach to Antibiotic Discovery , 2020, Cell.
[46] Peter D. Kwong,et al. Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4 , 2007, Science.
[47] X. Qiu,et al. Structures of protective antibodies reveal sites of vulnerability on Ebola virus , 2014, Proceedings of the National Academy of Sciences.
[48] S. Ryu,et al. Broadly neutralizing anti-hepatitis B virus antibody reveals a complementarity determining region H3 lid-opening mechanism , 2007, Proceedings of the National Academy of Sciences.
[49] Baoshan Zhang,et al. Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 , 2013, Nature Structural &Molecular Biology.
[50] S. Zolla-Pazner,et al. Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies , 2010, Nature Structural &Molecular Biology.
[51] M. Luftig,et al. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate–directed antibody , 2006, Nature Structural &Molecular Biology.
[52] A. M. Leontovich,et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.
[53] A. Gittis,et al. Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein. , 2007, Virology.
[54] Tianqi Chen,et al. XGBoost: A Scalable Tree Boosting System , 2016, KDD.
[55] Yang Liu,et al. Secondary attack rate and superspreading events for SARS-CoV-2 , 2020, The Lancet.
[56] I. Wilson,et al. Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10. , 2016, Immunity.
[57] T. Oliphant,et al. Structural basis of West Nile virus neutralization by a therapeutic antibody , 2005, Nature.
[58] Yuntao Wu,et al. Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools , 2020, Virologica Sinica.
[59] N. Bastien,et al. Analysis of multimerization of the SARS coronavirus nucleocapsid protein , 2004, Biochemical and Biophysical Research Communications.
[60] S. Henikoff,et al. Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[61] Yan Liu,et al. A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield , 2011, Science.
[62] J. Skehel,et al. Structural evidence for recognition of a single epitope by two distinct antibodies , 2000, Proteins.
[63] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[64] Qiang Zhou,et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.
[65] J. Skehel,et al. A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins , 2011, Science.
[66] Martin H. Koldijk,et al. A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses , 2011, Science.
[67] Craig R. Miller,et al. Initiating a watch list for Ebola virus antibody escape mutations , 2016, PeerJ.
[68] E. Pai,et al. Germline V‐genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus , 2008, The EMBO journal.
[69] V. Tugarinov,et al. NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding. , 2000, Structure.
[70] Tongqing Zhou,et al. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 , 2010, Science.
[71] P. Pandolfi,et al. Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses , 2020, Cell Research.
[72] J. Berg,et al. Molecular dynamics simulations of biomolecules , 2002, Nature Structural Biology.
[73] Damien Fleury,et al. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site , 1999, Nature Structural Biology.
[74] Thomas J Lane,et al. MDTraj: a modern, open library for the analysis of molecular dynamics trajectories , 2014, bioRxiv.
[75] A. Sharff,et al. Structure of a core fragment of glycoprotein H from pseudorabies virus in complex with antibody , 2010, Proceedings of the National Academy of Sciences.
[76] B. Haynes,et al. Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design , 2016, Journal of Virology.
[77] Structural basis for the antibody neutralization of Herpes simplex virus , 2013, Acta crystallographica. Section D, Biological crystallography.
[78] Berk Hess,et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers , 2015 .
[79] John P. Moore,et al. Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer , 2013, Science.
[80] Richard J Kuhn,et al. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins , 2008, Nature Structural &Molecular Biology.
[81] Berk Hess,et al. LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..
[82] Amir Barati Farimani,et al. Combining Physics-Based and Evolution-Based Methods to Design Antibodies Against an Evolving Virus , 2020 .
[83] P. Kwong,et al. Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F , 2010, Journal of Virology.
[84] Peter A. Flach,et al. Advances in Neural Information Processing Systems 28 , 2015 .
[85] Dafna M. Abelson,et al. Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain. , 2008, Journal of molecular biology.
[86] Ron Diskin,et al. Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design , 2011, Science.
[87] S. Zolla-Pazner,et al. Crystal Structures of Human Immunodeficiency Virus Type 1 (HIV-1) Neutralizing Antibody 2219 in Complex with Three Different V3 Peptides Reveal a New Binding Mode for HIV-1 Cross-Reactivity , 2006, Journal of Virology.
[88] Khaoula Ben Abdellafou,et al. Enhanced SVM-KPCA Method for Brain MR Image Classification , 2020, Comput. J..
[89] William C. Hwang,et al. Structural Basis of Neutralization by a Human Anti-severe Acute Respiratory Syndrome Spike Protein Antibody, 80R* , 2006, Journal of Biological Chemistry.
[90] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[91] L. Enjuanes,et al. Structural Bases of Coronavirus Attachment to Host Aminopeptidase N and Its Inhibition by Neutralizing Antibodies , 2012, PLoS pathogens.
[92] Alán Aspuru-Guzik,et al. Convolutional Networks on Graphs for Learning Molecular Fingerprints , 2015, NIPS.
[93] Elena Zaitseva,et al. Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus , 2012, The EMBO journal.
[94] Shaoqiang Li,et al. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis , 2020, Journal of medical virology.
[95] Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody , 2020, Emerging microbes & infections.
[96] E. Domingo,et al. A multiply substituted G-H loop from foot-and-mouth disease virus in complex with a neutralizing antibody: a role for water molecules. , 2000, The Journal of general virology.
[97] D. Kirchhofer,et al. Structural insight into distinct mechanisms of protease inhibition by antibodies , 2007, Proceedings of the National Academy of Sciences.
[98] Mario Roederer,et al. Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing , 2011, Science.
[99] D. Burton,et al. Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1 , 2012, Proceedings of the National Academy of Sciences.
[100] C. Midgley,et al. Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity , 2012, The Journal of Immunology.
[101] W G Laver,et al. The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody. , 1994, Structure.